LNG Market 2021 Development Trends

(EMAILWIRE.COM, August 15, 2017 ) This report studies LNG in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022 This report focuses on top manufacturers... more

Respiratory Drugs Global Key Market Developments and Strategies, 2016 Analysis and Forecat to 2022

(EMAILWIRE.COM, August 15, 2017 ) Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way The respiratory therapy area consists of indications that affect the respiratory system in... more

Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options Market Main Business Segments and Focus in the Generics Market Analysis 2016

(EMAILWIRE.COM, August 15, 2017 ) Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way The visual system, including the eye and its surrounding... more

Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Market Sales Forecast and Analysis 2016

(EMAILWIRE.COM, August 15, 2017 ) Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is the most common and aggressive human brain tumor, accounting for 15.4% of all primary brain tumors and 60-75% of all astrocytomas. It has a peak incidence between 55 and 84 years... more

Future of Generic Drugs and Strategies for Commercial Success Market Key Patent Expiry Dates and Potential Generic Competition Analysis 2016

(EMAILWIRE.COM, August 15, 2017 ) Publisher’s latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the global generic drugs market, and the evolving business strategies being adopted and leveraged by generic drug companies around the world. Publisher... more

Myosin Inhibitors -Pipeline Insights, 2016

(EMAILWIRE.COM, August 15, 2017 ) "Myosin Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Myosin Inhibitors. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical,... more

Myoclonic Seizures-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

(EMAILWIRE.COM, August 15, 2017 ) Report, "Myoclonic Seizures-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the... more

Myelodysplastic Syndrome-Market Insights Epidemiology and Market Forecast-2023

(EMAILWIRE.COM, August 15, 2017 ) Myelodysplastic Syndrome -Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and... more

Mycoses-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

(EMAILWIRE.COM, August 15, 2017 ) Report, "Mycoses-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Mycoses Report... more

Mycamine -Drug Insights, 2016

(EMAILWIRE.COM, August 15, 2017 ) Publisher Drug Report, "Mycamine- Drug Insights, 2016" highlights the Mycamine marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Mycamine covering the total... more

Musculoskeletal Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

(EMAILWIRE.COM, August 15, 2017 ) Report, "Musculoskeletal Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the... more

Muscarinic Acetylcholine Receptor M1 Antagonists - Pipeline Insights, 2016

(EMAILWIRE.COM, August 15, 2017 ) Publisher's, "Muscarinic Acetylcholine Receptor M1 Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Muscarinic Acetylcholine Receptor M1 Antagonists. The Publisher's Report covers... more

Mucositis-Pipeline Insights, 2016

(EMAILWIRE.COM, August 15, 2017 ) " Mucositis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Mucositis. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase... more

Mucodyne -Drug Insights, 2016

(EMAILWIRE.COM, August 15, 2017 ) Publisher Drug Report, "Mucodyne- Drug Insights, 2016" highlights the Mucodyne marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Mucodyne covering the total... more

mTORC-2 Inhibitors - Pipeline Insights, 2016

(EMAILWIRE.COM, August 15, 2017 ) Publisher's, "mTORC-2 Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the mTORC-2 Inhibitors. The Publisher's Report covers the product profiles in various stages of development... more